Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
A Phase 2, Open-label Study of Zanubrutinib (BGB-3111) in Patients with Relapsed or Refractory Marginal Zone Lymphoma
Opat, Stephen
(Primary Chief Investigator (PCI))
School of Clinical Sciences at Monash Health
Project
:
Research
Overview
Project Details
Project Description
NMA HREC Reference Number: HREC/18/CRGH/215 (ERM Project ID: 48385)
NMA SSA Reference Number: SSA/48385/MonH-2018-156789
Monash Health Ref: RES-18-0000-716X
Status
Active
Effective start/end date
14/12/18
→
13/12/23
View all
View less